跳至主要内容
临床试验/NCT01362933
NCT01362933已完成不适用

National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients

Floralis48 个研究点 分布在 1 个国家目标入组 502 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Floralis
入组人数
502
试验地点
48
主要终点
Evaluation of the adherence to recommendations of VTE treatment in cancer patients

研究概览

简要总结

Treatment of venous thromboembolism in cancer patients is specific and has been validated in trials that favor the use of LMWH (Low Molecular Weight Heparin) instead of VKA (Vitamin K Antagonist) treatment during 6 months. International recommendations have diffused this option.It is necessary to evaluate the compliance of physicians to this treatment by measuring the number of patients with cancer treated with long term use of LMWH.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with cancer present in the clinic, hospital, out patients diagnosed with a VTE during the 6 previous months. VTE can be symptomatic or asymptomatic, can be located close to a central line, and of any type (DVT, PE, SVT)

排除标准

  • Patient already included in a trial studying antithrombotic therapy
  • Patient refusing the study
  • Patient under 18 and/or not competent to give informed consent

结局指标

主要结局

Evaluation of the adherence to recommendations of VTE treatment in cancer patients

时间窗: At baseline (J0)

Proportion of patients treated for evolutive VTE according to international recommandations Patients could be hospitalised or could be out patient

次要结局

  • Proportion of asymptomatic VTE disease for this population(At baseline (J0))
  • Evaluation of VTE disease according to cancer diagnosis (proportion of SVT (Superficial Venous Thrombosis), DVT (Deep Venous Thrombosis), PE (Pulmonary Embolism)(At baseline (J0))
  • Feasibility of self injections for VTE treatment in cancer patients.(At baseline (J0))
  • Proportion of patients with catheter thrombosis(At baseline (J0))

研究者

发起方
Floralis
申办方类型
Industry
责任方
Sponsor

研究点 (48)

Loading locations...

相似试验